What is the appropriate management for a child with acute severe asthma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acute Severe Asthma in a 5-Year-Old Child

Immediately administer high-flow oxygen via face mask, nebulized salbutamol 5 mg (or terbutaline 10 mg), intravenous hydrocortisone, and add ipratropium 100 mcg nebulized every 6 hours—this is the standard immediate treatment protocol for acute severe asthma in children. 1

Initial Recognition and Assessment

Recognize acute severe asthma in this 5-year-old by identifying these clinical features:

  • Too breathless to talk or feed 1
  • Respirations >50 breaths/min 1
  • Pulse >140 beats/min 1
  • Peak expiratory flow (PEF) <50% predicted (if measurable) 1

Life-threatening features requiring even more aggressive management include:

  • PEF <33% predicted 1
  • Cyanosis, silent chest, or fatigue/exhaustion 1
  • Poor respiratory effort 1
  • Agitation or reduced level of consciousness 1

Important caveat: Children with severe attacks may not appear distressed and may not have all these abnormalities—the presence of any should alert you. 1 Assessment in very young children may be difficult. 1

Immediate Treatment Protocol (First 15-30 Minutes)

Step 1: Administer simultaneously:

  • Intravenous hydrocortisone immediately 1, 2, 3
  • High-flow oxygen via face mask to maintain SaO₂ >92% 1, 2, 3
  • Nebulized salbutamol 5 mg (or terbutaline 10 mg) via oxygen-driven nebulizer 1, 2, 3
  • Add ipratropium 100 mcg nebulized every 6 hours 1, 2, 3

Note: The British Thoracic Society guidelines specify half doses in very young children, but at age 5, use the full pediatric dose of salbutamol 5 mg. 1

Step 2: If life-threatening features are present:

  • Give intravenous aminophylline 5 mg/kg over 20 minutes followed by maintenance infusion of 1 mg/kg/h 1, 3
  • Omit the loading dose if the child is already receiving oral theophyllines 1, 3

Step 3: Monitoring during initial treatment:

  • Repeat PEF measurement 15-30 minutes after starting treatment (if appropriate for age) 1, 3
  • Maintain oximetry SaO₂ >92% 1, 3
  • Chart PEF before and after β-agonist administration at least 4 times daily 1, 3

Important: No other investigations are needed for immediate management. 1 Blood gas estimations are rarely helpful in deciding initial management in children. 1

Subsequent Management Based on Response

If Patient is Improving After 15-30 Minutes:

Continue:

  • High-flow oxygen 1, 3
  • Prednisolone 1-2 mg/kg body weight daily (maximum 40 mg) 1, 2, 3, 4
  • Nebulized β-agonist 4 hourly 1, 3

If Patient is NOT Improving After 15-30 Minutes:

Escalate treatment:

  • Continue oxygen and steroids 1, 3
  • Give nebulized β-agonist more frequently, up to every 30 minutes 1, 3
  • Add ipratropium to nebulizer and repeat 6 hourly until improvement starts (if not already added) 1, 3

Critical point: The addition of ipratropium to beta-agonist therapy is specifically indicated when initial beta-agonist treatment fails, providing additional bronchodilation through a different mechanism. 3

Transfer to Intensive Care Unit

Transfer the patient to ICU accompanied by a doctor prepared to intubate if there is:

  • Deteriorating PEF or worsening exhaustion 1, 3
  • Feeble respirations, persistent hypoxia, or hypercapnia 1, 3
  • Coma, respiratory arrest, confusion, or drowsiness 1, 3

Systemic Corticosteroid Dosing Details

Oral prednisolone is the preferred route:

  • Dose: 1-2 mg/kg/day (maximum 40-60 mg/day) 1, 2, 4
  • Administer as soon as possible, ideally within the first hour 2
  • Continue until PEF reaches 70% of predicted or personal best, or for 3-10 days for outpatient treatment 2
  • The National Heart, Lung, and Blood Institute recommends 1-2 mg/kg/day in single or divided doses for children whose asthma is uncontrolled 4

Common pitfall to avoid: Do not delay systemic corticosteroids while continuing to give repeated doses of albuterol alone—if the patient has failed initial beta-agonist treatment, escalation with steroids is mandatory. 3

Discharge Criteria

Children should meet ALL of the following before discharge:

  • Been on discharge medication for 24 hours with inhaler technique checked and recorded 1, 3
  • PEF >75% of predicted or best and PEF diurnal variability <25% (if recorded) 1, 3
  • Treatment with soluble steroid tablets and inhaled steroids in addition to bronchodilators 1, 3
  • Own PEF meter and self-management plan or written instructions for parents 1, 3
  • GP follow-up arranged within 1 week 1, 3
  • Follow-up appointment in respiratory clinic within 4 weeks 1, 3

Alternative Treatment Considerations

If nebulizer is unavailable:

  • Administer 10-20 puffs of salbutamol via metered-dose inhaler with large volume spacer, which is equivalent to one 5 mg nebulization treatment 5
  • Each puff delivers approximately 100 mcg of salbutamol, so 10-20 puffs provides 1-2 mg total dose 5

Recent evidence on inhaled corticosteroids:

  • High-dose inhaled corticosteroids are at least as effective as oral corticosteroids in controlling moderate to severe asthma attacks in children and should be considered an alternative 6
  • However, oral prednisolone remains the treatment of choice for the most severe exacerbations when airways are extremely contracted and filled with secretions 6

Key Points on Adjunctive Therapies

Ipratropium bromide:

  • Should only be given in addition to β₂-agonists, not as monotherapy 6
  • Particularly beneficial when initial beta-agonist treatment fails 3

Theophylline:

  • Has no additional benefit beyond standard therapy 6

Magnesium sulfate:

  • Has no clear advantage in routine management 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Asthma Exacerbation Management in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute Asthma Exacerbation Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Pediatric Asthma in the Yellow Zone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.